The clear treatment for canine OA.
Recognize the source of OA inflammation and pain in dogs,
and the treatment becomes clear. Galliprant effectively
controls both inflammation and pain, without tradeoffs.
INDICATION
Galliprant
®
(grapiprant tablets) is an NSAID indicated for the control of pain and inflammation associated with osteoarthritis in dogs.
IMPORTANT SAFETY INFORMATION
Not for use in humans. For use in dogs only. Keep this and all medications out of reach of children and pets. Store out of reach of dogs and other pets in a secured location in order
to prevent accidental ingestion or overdose. Do not use in dogs that have a hypersensitivity to grapiprant. If Galliprant is used long term, appropriate monitoring is recommended.
Concomitant use of Galliprant with other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids, should be avoided. Concurrent use with other anti-inflammatory
drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used
for breeding, pregnant or lactating dogs, or dogs with cardiac disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite, and lethargy. Please visit
galliprantfordogs.com/vet for full prescribing information.
©2024 Elanco or its affiliates.
Galliprant, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. PM-US-24-0143
See how Galliprant works:
Visit GalliprantVet.com
Available now from MyCovetrus.com
